BioSpace News Archive

Policy

Fifty Tablo Mobile Dialysis Systems Deployed to New York Hospitals by U.S. Department of Health and Human Services for COVID-19 Disaster Recovery Response

NYC and Long Island receive first-ever HHS emergency deployment of Outset Medical’s easy-to-use technology for patients with kidney failure

May 7, 2020
·
3 min read
Deals

Zoetis Announces Pricing of $1.25 Billion of Senior Notes - May 08, 2020

Zoetis Inc. announced that it has agreed to sell $1.25 billion of senior notes, consisting of $750 million aggregate principal amount of 2.000% senior notes due 2030 and $500 million aggregate principal amount of 3.000% senior notes due 2050, in an underwritten public offering.

May 7, 2020
·
3 min read
Biotech Beach

Axonics® Announces Pricing of Public Offering of Common Stock

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), today announced the pricing of its public offering of 4,000,000 shares of its common stock at a public offering price of $32.50 per share, before underwriting discounts and commissions.

May 7, 2020
·
4 min read
Business

Neovasc Announces First Quarter 2020 Financial Results

Neovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, reported financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
10 min read
Business

REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights

Positive long-term and interim data update from RGX-314 Phase I/IIa trial for wet AMD recently announced

May 7, 2020
·
13 min read
Business

BIOLASE Reports First Quarter 2020 Financial Results

BIOLASE, Inc., the global leader in dental lasers, announced its financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
7 min read
Business

Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update

Final OS analysis for Phase 3 E2112 trial in HR+, HER2- metastatic breast cancer expected this quarter; potential NDA filing later this year

May 7, 2020
·
12 min read
Business

Provention Bio Reports First Quarter 2020 Financial Results and Provides Business Update

Company on Track to Complete Submission of Rolling Biologics License Application for Teplizumab in Q4 2020

May 7, 2020
·
8 min read
Business

Penumbra, Inc. Reports First Quarter 2020 Financial Results

Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
8 min read
Business

PDL BioPharma Reports 2020 First Quarter Financial Results

PDL BioPharma, Inc. reports financial results for the three months ended March 31, 2020 and provides a business update

May 7, 2020
·
15 min read